All it takes is one name
I wouldn't say they had to beat the doors down into AstraZeneca, Memorial Sloan Kettering and NCCN (which consists of 26 top US cancer hospitals..), would you?
I mean did you see the MSK crew all smiles with Peregrine crew last year?
Certainly didn't look like they beat their doors down at all and I wonder what plan is in place that the competitors don't know much about : )
Robert Ralston Univ of Kansas Medical Center closer to Merck or BMS or who knows, he may know exactly that flipped PS must be targeted
Heck, even ex-Medarex Kent Thudium is right in the mix and knows as much as Robert Ralston
The funny thing is all it takes is one Big Pharma to strike the biggest deal with Peregrine Pharmaceuticals and all it takes is one name to crush the going ons in certain Big Pharma operations
In the mean time, seems like an awfully lot of negativity showing up around here parts all to save us all from PS Targeting : )
I'll stick with the yellow stickies and buy low and sell high
... lately though, its buy lower and will be sell much much higher
"Bavituximab is a first-in-class phosphatidylserine (PS)-targeting monoclonal antibody that is the cornerstone of a broad clinical
pipeline." -- Big Pharmas nightmare... unless they are fortunate enough to have The Bavi Edge!
AI
